A recent CNN article contained good news for people who prefer not to have swabs inserted deep into their nostrils. The FDA has granted emergency use authorization for a COVID-19 breath test. The diagnostic tool identifies chemical compounds associated with the virus in breath, and can be used in medical offices and mobile testing sites. The test is called the InspectIR Covid-19 Breathalyzer, and it detects five compounds associated with SARS-CoV-2 infections. A study on the device found that it was able to accurately identify 91% of positive samples, and virtually 100% of negative samples. A video with more information can be seen here. Finally, a breathalyzer I wouldn’t mind taking!
FDA Clears First COVID-19 Breath Test
Move over painful swabs, now we have a breathalyzer that identifies compounds associated with SARS-CoV-2 infections.
Apr 22, 2022
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now